|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of Cyclacel Pharmaceuticals (NASDAQ: CYCC) through any online brokerage.
The latest price target for Cyclacel Pharmaceuticals (NASDAQ: CYCC) was reported by Oppenheimer on April 30, 2021. The analyst firm set a price target for 17.00 expecting CYCC to rise to within 12 months (a possible 214.81% upside). 1 analyst firms have reported ratings in the last year.
The stock price for Cyclacel Pharmaceuticals (NASDAQ: CYCC) is $5.4 last updated Fri Sep 24 2021 20:00:02 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Cyclacel Pharmaceuticals. The last dividend paid out to investors was $0.10 on July 13, 2016.
There is no upcoming split for Cyclacel Pharmaceuticals.
Cyclacel Pharmaceuticals is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.